Skip to main content
PCI Biotech Holding logo

PCI Biotech Holding — Investor Relations & Filings

Ticker · PCIB ISIN · NO0010405640 LEI · 5967007LIEEXZXFIGG77 OL Manufacturing
Open in API
Filings indexed 752 across all filing types
Latest filing 2010-08-17 Report Publication Anno…
Country NO Norway
Listing OL PCIB

About PCI Biotech Holding

https://www.pcibiotech.no/

PCI Biotech Holding is a biopharmaceutical company developing therapeutic products based on its proprietary Photochemical Internalization (PCI) technology. This platform is a drug and nucleic acid delivery system designed to enhance the intracellular delivery of therapeutic molecules. The company's development programs are focused on applications in immunotherapy, dermatology, and bioprocessing for the manufacturing of viral vectors. A primary therapeutic area for the technology is cancer, where it aims to improve the efficacy of novel and existing treatments.

Recent filings

Filing Released Lang Actions
Presentation of second quarter 2010 results
Report Publication Announcement Classification · 99% confidence The document is a short announcement (721 characters) inviting stakeholders to a presentation of the company's Q2 2010 results. It does not contain the actual financial results or the presentation slides themselves, but rather serves as a notification of the event's time and location. Following the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement (RPA).
2010-08-17 English
Presentasjon av resultater for andre kvartal 2010
Report Publication Announcement Classification · 95% confidence The document is a short announcement (651 characters) inviting stakeholders to a presentation of the company's Q2 2010 results. It provides the date, time, and location of the event and contact information. Per the 'Menu vs Meal' rule, since this is a short announcement regarding an upcoming event rather than the financial report itself, it is classified as a Report Publication Announcement (RPA).
2010-08-17 Norwegian
Ny aksjekapital
Share Issue/Capital Change Classification · 100% confidence The document announces a change in share capital (aksjekapital) following a rights issue (fortrinnsrettsemisjon). It specifies the new total share capital and the number of shares, which directly relates to a change in the company's capital structure. This fits the definition of a share issue or capital change announcement.
2010-06-21 Norwegian
New share capital
Share Issue/Capital Change Classification · 100% confidence The document announces a change in share capital following a rights offering, specifically detailing the new share capital amount, the number of shares, and the registration of these shares with the Norwegian Register of Business Enterprises. This falls under the category of share capital changes and new share issues.
2010-06-21 English
Endelig resultat i emisjon
Share Issue/Capital Change Classification · 100% confidence The document details the final results of a share issuance (emisjon) by PCI Biotech Holding ASA, including the number of shares issued, the subscription price, the total proceeds raised, and the resulting change in share capital. This falls under the category of share issuance and capital changes.
2010-06-15 Norwegian
Final results of the rights offering
Share Issue/Capital Change Classification · 100% confidence The document details the final results of a rights offering, including the number of shares allocated, the subscription process, the gross proceeds raised, and the resulting increase in share capital. This falls under the category of share issuance and capital changes.
2010-06-15 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.